The sweeter side of ACE2: physiological evidence for a role in diabetes.
about
Multifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatmentThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus.Classical Renin-Angiotensin system in kidney physiologySex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent.Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.Angiotensin-converting enzyme 2: the first decade.Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.Angiotensin-(1-7)-mediated signaling in cardiomyocytes.The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndromeAngiotensin converting enzyme 2: a new important player in the regulation of glycemia.The renin angiotensin aldosterone system and insulin resistance in humans.Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.Angiotensin-Converting Enzyme 2 Deficiency Aggravates Glucose Intolerance via Impairment of Islet Microvascular Density in Mice with High-Fat Diet.High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?The renin-angiotensin system: a link between obesity, inflammation and insulin resistance.The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond.Brain renin-angiotensin system in the nexus of hypertension and agingOpportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications.Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Renin-angiotensin system: an old player with novel functions in skeletal muscle.Glucagon-producing cells are increased in Mas-deficient mice.Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade.Response to comment on: Takeda et al. Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes 2013;62:223-233.Comment on: Takeda et al. Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes 2013;62:223-233.High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice.Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts.Neuromuscular electrostimulation and insulin sensitivity in patients with type 2 diabetes: the ELECTRODIAB pilot study.Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells.Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
P2860
Q28086792-355B62C5-C215-4FBB-BDA4-BDEE81AD1213Q30486745-B1C6DE7E-8129-4659-9BAF-523283CAA523Q33800185-9A59FD16-14E0-4B83-80DF-805FA651DE56Q34065655-3EEFBDE5-C53B-4F7B-B49E-151CD10E2FF8Q34439831-79E4BE63-1F11-4E48-B389-6F89FE295848Q34480216-6C5A2E58-7E0C-4B8B-9DD1-ABCECBF8349DQ35550937-86925FA7-7E39-4162-B37A-738EE06A712FQ35757097-7E3F7096-78A6-4085-B06B-7D85CDB6073AQ35829928-F0AE3E90-5E23-4AE5-9271-D53B7AC45B1FQ35850133-F134368C-F3AB-4B16-B84C-B162D686F8FFQ36020040-A8059003-88BF-476C-B9CF-C1DEC891AED1Q36550987-2A8062DF-03AC-49AC-8AD2-872A643225ACQ36764034-48D43072-A02F-4B61-A711-814422129242Q36825669-8E9A3F64-2BC3-4508-99BA-5C0BACD0A5BFQ37265803-68DA42CC-2384-4467-977C-16B2F0CED59CQ37347190-AB5F9586-2F04-4FDB-A85D-A6623E9724C4Q37950397-801C35E4-7BC9-4A7E-971B-754A7116DAA6Q38034805-3E071BB4-86A1-4E12-8F70-F109B6EF27A8Q38053075-E440F07F-B00B-4966-9CE6-2B945E8F0594Q38065112-5ADA729F-2CC3-4CDD-84EE-6AE0115B273AQ38170474-60D731BD-F236-4154-BD98-6ACDA49B79C9Q38190099-93EE6566-AD78-4F6A-928C-3EF0EEB5CDCCQ38375202-F9ACAFC2-7A59-47DC-A520-CDCC9F6A9C2BQ42009046-AA47E415-750B-4741-B632-5D1139E66DB0Q42330055-DAE621BE-1188-4B1D-9B66-B90F78346429Q43090899-0D5A1ED2-967E-4916-88A6-249E5C0BD958Q43090939-2413C20A-A900-497E-99D3-48BEF8A8DD04Q45848259-B8B8D42A-1CD3-4643-A2E3-80F8DDFD05F3Q47871649-D265C61F-43C0-4B2F-8595-0C4FADE12337Q48119889-BF61B183-BBEB-4824-BD3B-AA8CCB3B8549Q53151267-DEA04E5E-4A8B-444F-936B-D89686F09C2BQ54289492-D29B6DBA-ABBD-4D19-987F-EB79A956A001Q54496318-6969E659-765D-40F1-AF4E-1EB3C4CE7B33
P2860
The sweeter side of ACE2: physiological evidence for a role in diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The sweeter side of ACE2: physiological evidence for a role in diabetes.
@en
The sweeter side of ACE2: physiological evidence for a role in diabetes.
@nl
type
label
The sweeter side of ACE2: physiological evidence for a role in diabetes.
@en
The sweeter side of ACE2: physiological evidence for a role in diabetes.
@nl
prefLabel
The sweeter side of ACE2: physiological evidence for a role in diabetes.
@en
The sweeter side of ACE2: physiological evidence for a role in diabetes.
@nl
P2860
P1476
The sweeter side of ACE2: physiological evidence for a role in diabetes.
@en
P2093
Eric Lazartigues
Sharell M Bindom
P2860
P304
P356
10.1016/J.MCE.2008.09.020
P577
2008-10-01T00:00:00Z